Showing results (61-70 of 147) with videos related to
Sort By:
Pageof 15
Trials|August 9, 2022
Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trialsThomas Williams, Sarah Alexander, James Blackstone, et al.Neurology|June 5, 2021
Secondary Progressive Multiple Sclerosis: New InsightsBruce A C Cree, Douglas L Arnold, Jeremy Chataway, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 16, 2015
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribineJulia Pakpoor, Giulio Disanto, Daniel R Altmann, et al.European Journal of Neurology|April 17, 2026
Erythrocyte Fragility in Progressive Multiple SclerosisCarmen Jacob, Thomas E Williams, Charlotte M Stuart, et al.Multiple Sclerosis and Related Disorders|November 27, 2018
Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesisIeva Eskyte, Ana Manzano, George Pepper, et al.The Lancet. Neurology|July 13, 2010
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trialRaju Kapoor, Julian Furby, Thomas Hayton, et al.Practical Neurology|May 22, 2020
How to diagnose difficult white matter disordersThomas Williams, Henry Houlden, Elaine Murphy, et al.Neurology(R) Neuroimmunology & Neuroinflammation|January 15, 2022
Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled TrialThomas E Williams, Katherine P Holdsworth, Jennifer M Nicholas, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 11, 2015
The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseasesNidhi Garg, Stephen W Reddel, David H Miller, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Enhancing diversity of clinical trial populations in multiple sclerosisRuth Ann Marrie, Jeremy Chataway, Barbara E Bierer, et al.Pageof 15